Choline Salicylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Choline Salicylate, covering 2026-01-06 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma [Phase 1]